Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
BRINAVESS Inf Konz 500 mg/25ml Durchstf 25 ml
Drug
Brinavess, Konzentrat zur Herstellung einer Infusionslösung
Antiarrhythmikum
02.02.0. – antiarrhythmics
HAM – Human medicine
KOPA – Parenteral concentrate
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
3/16/2011
12/31/9999
Dosage strength
Brinavess 500 mg, Konzentrat zur Herstellung einer Infusionslösung
Antiarrhythmikum
02
Z – approved
Package
7680613040032
No information made available
A/R – Authorised / referenced
1 vial(s)
003
Z – approved
Declaration
Component
500 mg vernakalanti hydrochloridum
452.5 mg vernakalantum
452.5 mg vernakalantum
acidum citricum monohydricum
natrii chloridum
natrii hydroxidum
aqua ad iniectabile
78.75 mg natrium
natrii chloridum
natrii hydroxidum
aqua ad iniectabile
78.75 mg natrium
Spezialitätenliste***
This package has been removed from the list of specialties. The displayed data correspond to the latest status.
SL
2/1/2023
4/30/2023
496.35
None
Yes
10%
No
Authorisation holder
7640109110007
Curatis AG
Weierweg 7
4410 Liestal (BL)
Weierweg 7
4410 Liestal (BL)
Date of revision of the text
6/29/2023
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.